ExodusPoint Capital Management’s Twist Bioscience TWST Stock Holding History

ExodusPoint Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-471,829	Closed	-$17.4M	–	2037
2025 Q2	$17.4M	Buy	471,829 +43,092	+10%	+$1.49M	0.15%	134
2025 Q1	$16.8M	Buy	428,737 +389,437	+991%	+$17.5M	0.17%	118
2024 Q4	$1.83M	Buy	+39,300	New	+$1.78M	0.01%	748
2024 Q1	–	Sell	-10,237	Closed	-$377K	–	1974
2023 Q4	$377K	Buy	+10,237	New	+$237K	﹤0.01%	1113
2023 Q3	–	Sell	-18,653	Closed	-$382K	–	2160
2023 Q2	$382K	Buy	+18,653	New	+$279K	﹤0.01%	1450
2023 Q1	–	Sell	-32,179	Closed	-$766K	–	2139
2022 Q4	$766K	Buy	32,179 +13,959	+77%	+$405K	0.01%	1038
2022 Q3	$642K	Buy	+18,220	New	+$774K	0.01%	1279
2022 Q1	–	Sell	-4,887	Closed	-$378K	–	2693
2021 Q4	$378K	Buy	+4,887	New	+$502K	﹤0.01%	1559
2021 Q2	–	Sell	-5,850	Closed	-$725K	–	2816
2021 Q1	$725K	Buy	+5,850	New	+$888K	0.01%	1117

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

ExodusPoint Capital Management's TWST Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 471,829 shares — an estimated $17.4M sold.

ExodusPoint Capital Management first reported a position in TWST in Q1 2021 and held it in 9 quarters. The position peaked at $17.4M in Q2 2025. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

ExodusPoint Capital Management reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 471,829 Twist Bioscience shares in Q3 2025, an estimated $17.4M.
ExodusPoint Capital Management first reported a position in Twist Bioscience in Q1 2021 and held it in 9 quarters.
ExodusPoint Capital Management's Twist Bioscience position peaked at $17.4M in Q2 2025.
238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.